Cargando…
Improved Survival of HIV-1-Infected Patients with Progressive Multifocal Leukoencephalopathy Receiving Early 5-Drug Combination Antiretroviral Therapy
BACKGROUND: Progressive multifocal leukoencephalopathy (PML), a rare devastating demyelinating disease caused by the polyomavirus JC (JCV), occurs in severely immunocompromised patients, most of whom have advanced-stage HIV infection. Despite combination antiretroviral therapy (cART), 50% of patient...
Autores principales: | Gasnault, Jacques, Costagliola, Dominique, Hendel-Chavez, Houria, Dulioust, Anne, Pakianather, Sophie, Mazet, Anne-Aurélie, de Goer de Herve, Marie-Ghislaine, Lancar, Rémi, Lascaux, Anne-Sophie, Porte, Lydie, Delfraissy, Jean-François, Taoufik, Yassine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127950/ https://www.ncbi.nlm.nih.gov/pubmed/21738597 http://dx.doi.org/10.1371/journal.pone.0020967 |
Ejemplares similares
-
Efficacy of Recombinant Human Interleukin 7 in a Patient With Severe Lymphopenia-Related Progressive Multifocal Leukoencephalopathy
por: Gasnault, Jacques, et al.
Publicado: (2014) -
B Cells and Progressive Multifocal Leukoencephalopathy: Search for the Missing Link
por: Durali, Deniz, et al.
Publicado: (2015) -
Refractory T-Cell Anergy and Rapidly Fatal Progressive Multifocal Leukoencephalopathy After Prolonged CTLA4 Therapy
por: Dekeyser, Manon, et al.
Publicado: (2017) -
Editorial: Immune Control of JC Virus Infection and Immune Failure during Progressive Multifocal Leukoencephalopathy
por: Taoufik, Yassine, et al.
Publicado: (2017) -
Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy
por: Eis, Peggy S., et al.
Publicado: (2020)